ABUS News and Press, Arbutus Biopharma Corporation

2026-03-04 11:05:30 ET Thesis As you now know, Moderna, Inc.’s ( MRNA ) settlement with Arbutus Biopharma ( ABUS ) and Genevant Science ( ROIV ) is going to require a pretty hefty upfront payment of $950 million. However, as I will explain, I think this ou...

2026-03-04 09:18:05 ET More on Moderna, Arbutus Biopharma, etc. Roivant Sciences Ltd. (ROIV) Discusses $2.25 Billion Global Settlement Resolving COVID Vaccine Patent Litigation Transcript Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript...

2026-03-03 17:16:52 ET More on Moderna Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation EMA recommends au...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion payment is realized, this settlement will be the largest disclosed patent settlement paid in the pharmaceutic...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion payment is realized, this settlement will be the largest disclosed patent settlement paid in the pharmaceutic...

2026-02-18 09:42:45 ET More on Moderna Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna gains as FDA backtracks and accept...

2026-02-03 07:48:04 ET Thesis: A busy few months for Arbutus Arbutus Biopharma Corporation ( ABUS ) stock has gotten off to a pretty rocky start in 2026. Shares are down about 10% on the one-month chart as a patent dispute with Moderna ( MRNA ) has escalated in January. Init...

2026-02-02 14:21:12 ET More on Arbutus Biopharma Arbutus falls as patent dispute with Moderna hits EU snag Seeking Alpha’s Quant Rating on Arbutus Biopharma Historical earnings data for Arbutus Biopharma Financial information for Arbutus Biopharma ...

2026-01-16 08:41:17 ET More on Arbutus Biopharma, Moderna Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story 44th Annual J.P. Morgan Healthcare Conference Moderna, Inc. (MRNA) Presents at 44th Annual J.P. Morgan Healthcare Conference Tr...

2025-11-13 08:04:56 ET More on Arbutus Biopharma Arbutus: IP Drama With High Stakes Seeking Alpha’s Quant Rating on Arbutus Biopharma Historical earnings data for Arbutus Biopharma Financial information for Arbutus Biopharma Read the full art...